about
Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.Irritable bowel syndrome and chronic constipation: Fact and fictionThe epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine.Infectious diseases in the Tuscan detention setting: data from the Health Agency of Tuscany.Attempt to calculate the prevalence and features of chronic hepatitis C infection in Tuscany using administrative dataIrritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapyEvaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study.Health conditions of inmates in ItalyAssessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment.Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis.Functions of Ghrelin in Brain, Gut and Liver.Screening of distress among hospitalized patients in a department of internal medicine.Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study.Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry.Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany.Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot StudyDeregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.Epidemiology of Liver Cirrhosis.Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.Evolving strategies for liver fibrosis staging: Non-invasive assessment.Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron.Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?Prevalence and features of chronic viral hepatitis and HIV coinfection in Italian prisons.Neuroendocrine markers and psychological features in patients with irritable bowel syndrome.Simulation of real-time deformable soft tissues for computer assisted surgery.Epidemiological, demographic and clinical data on chronic viral hepatitis C in TuscanyLiver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritisReliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis CThe general practitioner's approach to irritable bowel syndrome: from intention to practiceThe general practitioner's management of patients with a new diagnosis of irritable bowel syndromeHepatitis B and C epidemiology in an urban cohort in Tuscany (Italy)DRESS syndrome in a patient with chronic hepatic encephalopathyHepatitis B vaccination and immunotherapies: an updateComparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver diseaseLongitudinal evaluation of liver stiffness and outcomes in patients with chronic hepatitis C before and after short- and long-term IFN-free antiviral treatment
P50
Q26773187-9E203D97-EEF6-48DE-86FE-9D803C190F0AQ26777547-2B95E093-7BCB-415A-92A0-30D4E38E9F96Q30252122-F0412618-1DB1-4FEF-8F51-3193A65BD42DQ31087300-68E73B6F-CB0B-4B97-AC52-325BAD026482Q31148392-1B8B75E6-E859-4391-874C-7B2B1D02EEC5Q33958808-29EC1DBA-44CB-42D2-AB14-1FEE22D90002Q35169370-F732619B-94D7-4B09-B8CC-54CBEC2C0050Q36194510-941FC0B7-F1F6-4882-A9B1-1F021CF23834Q37532286-CEBCDAA6-9A94-45A8-8A18-07790BA6FC98Q38024260-61391BCA-6EFB-4029-9AA6-39C31F7B1CFAQ38178543-208A9664-396C-4099-82A5-57A6B6B6C492Q38725506-C5CC45C5-2F00-4E27-82A7-875BD52DFEA8Q38863761-51D00029-2964-4C55-9895-CDEAB3F41E00Q38891289-E84949A9-DC9A-4507-B854-1EE047D87272Q39195514-51BFAA86-B446-4A69-BB23-C7BB43A79C51Q39487561-CCD33590-B153-408F-BAB2-B8D37FB2D3CAQ40246909-828120E0-8D65-46BF-80E6-050B2068428EQ40528517-EF900959-0BBC-4F59-A8D9-466C731B489CQ40839366-7CF0A642-2E46-496B-B715-0707D451C6B5Q40969307-A18F9581-9009-4D78-9805-010E958F9CDFQ41053182-21067261-FFA5-48FA-8BA2-AA9A14A789ADQ41079737-079D80C2-1D05-45A1-92F9-B563FC8FDE77Q41175619-4C8BD617-4740-4971-A883-B6102DC0C3C2Q42180401-8D6990EE-7107-43B6-9873-95ADDD6CCE56Q42330338-D9B404DC-08D4-4588-BA88-6BD0CA13C042Q44700991-B81C79A5-805E-460E-9CA4-DC8301CA1C67Q45471839-DAF819A7-6F47-4D64-8BEA-E149265A8225Q45766474-AE14467C-9086-4841-AD20-C5424764C0FBQ48178534-E0A25D8D-8CB7-44E2-9665-19B1526A0B5CQ51626537-96E9A65F-3F99-47FF-AD77-B72FF4C8827CQ56890279-9E180977-474B-4E57-B147-46EC8E518339Q61762977-BEC322C6-B5F4-4A96-BA48-5B1638940E37Q61763020-AB5C3B13-39A6-4CC4-B3FF-26E3203B82E4Q81390515-B86C952B-C344-43F4-9FD0-292FFB79396DQ81600141-015C289D-703D-46E4-8E27-0C9B5275F311Q87361305-4D744F78-6087-4414-82B4-69A8B7B45402Q88002886-18A947E9-9CDF-4D7F-A697-816A4C78527BQ89869088-0E2B7B85-1D73-4824-891C-0D8A473B7F04Q90869833-E4557A56-85A6-4A76-92FB-0EE2DEE88361Q91185803-A0B09FB6-3EF4-4803-9B2E-7469DB1C3B36
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristina Stasi
@ast
Cristina Stasi
@en
Cristina Stasi
@es
Cristina Stasi
@nl
type
label
Cristina Stasi
@ast
Cristina Stasi
@en
Cristina Stasi
@es
Cristina Stasi
@nl
prefLabel
Cristina Stasi
@ast
Cristina Stasi
@en
Cristina Stasi
@es
Cristina Stasi
@nl
P106
P1153
6602515850
P21
P31
P496
0000-0002-9146-9968